ロード中...
Screening Circular RNAs Related to Acquired Gefitinib Resistance in Non-small Cell Lung Cancer Cell Lines
Background: Gefitinib is a tyrosine kinase inhibitor (TKI) of epidermal growth factor receptor (EGFR) used to treat EGFR mutation-positive patients with non-small cell lung cancer (NSCLC). However, the efficacy of gefitinib is limited by the development of acquired resistance. Studies have shown tha...
保存先:
| 出版年: | J Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Ivyspring International Publisher
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7171488/ https://ncbi.nlm.nih.gov/pubmed/32328186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.39783 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|